Evidence map›Paper›PMID 33746602›Full record

ArticleInternational journal of medical sciences2021

Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.

Chi-I Chang, Shi-Yie Cheng, Annisa Oktafianti Nurlatifah, Wei-Wen Sung, Jing-Hong Tu, Lin-Lee Lee, Hsueh-Ling Cheng

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Therapeutic Potential of Momordicine I fromInternational journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Cytotoxic and Anti-Inflammatory Triterpenoids in the Vines and Leaves ofInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Antidiabetic Activity ofAvicenna journal of medical biotechnology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Chi-I ChangDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Shi-Yie ChengDepartment of Life Sciences, National University of Kaohsiung, Kaohsiung 811, Taiwan.
Annisa Oktafianti NurlatifahDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Wei-Wen SungDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Jing-Hong TuDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Lin-Lee LeeDepartment of English, National Kaohsiung Normal University, Kaohsiung 80201, Taiwan.
Hsueh-Ling ChengDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
National Pingtung University of Science and Technology · TWNational Kaohsiung Normal University · TWNational University of Kaohsiung · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestines have been recognized as important tissues for metabolic regulation, including glycemic control, but their vital role in promoting the anti-diabetic effects of bitter melon, the fruit of

Indexed as

Cell LineDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2EnterocytesEnteroendocrine CellsGlucagon-Like Peptide 1GlucoseHumansInsulinInsulin ResistanceIntestinal MucosaMomordica charantiaPlant ExtractsGlucagon-Like Peptide 1GlucoseInsulinPlant ExtractsAMP-activated protein kinasebitter-taste receptordiabetesglucagon-like peptide 1intestineMomordica charantia.

Identifiers

PMID33746602
PMCPMC7976585
OpenAlexW3138189538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.